FDA committee backs approval of Sarepta Therapeutics’ SRP-9001 for DMD

Pallavi Madhiraju- May 13, 2023 0

Sarepta Therapeutics’ SRP-9001 (delandistrogene moxeparvovec) has received the backing of the Cellular, Tissue and Gene Therapies Advisory Committee (CTGTAC) of the US Food and Drug ... Read More

Zydus Lifesciences gets FDA final approval for Sucralfate Tablets

Pallavi Madhiraju- May 7, 2023 0

Zydus Lifesciences has bagged final approval to manufacture and market Sucralfate Tablets USP, 1 gram from the US Food and Drug Administration (FDA). The approved ... Read More

EarlyTect BCD test : Promis Diagnostics gets FDA breakthrough designation

Pallavi Madhiraju- April 30, 2023 0

Promis Diagnostics has secured breakthrough device designation for its non-invasive EarlyTect BCD test from the US Food and Drug Administration (FDA) as a urine-based diagnosis ... Read More

Teva Pharmaceuticals, MedinCell get UZEDY FDA approval for schizophrenia

Pallavi Madhiraju- April 30, 2023 0

Teva Pharmaceuticals and MedinCell have bagged approval for UZEDY (risperidone) extended-release injectable suspension from the US Food and Drug Administration (FDA) for schizophrenia treatment in ... Read More

Zydus Lifesciences wins FDA final approval for Isoproterenol HCL injection

Pallavi Madhiraju- April 16, 2023 0

Zydus Lifesciences has secured final approval for Isoproterenol Hydrochloride (HCL) Injection USP, 0.2 mg/mL and 1 mg/5 mL (0.2 mg/mL) single-dose vials from the US ... Read More

Zydus Lifesciences bags FDA final approval for Tavaborole Topical Solution

Pallavi Madhiraju- April 12, 2023 0

Zydus Lifesciences has won final approval from the US Food and Drug Administration (FDA) for Tavaborole Topical Solution, 5%. The approved product is a generic ... Read More

Emergent’s Narcan nasal spray receives OTC nod for opioid overdose treatment

Raghuram Kadari- March 30, 2023 0

Emergent BioSolutions’ Narcan nasal spray has secured over-the-counter (OTC) designation from the US Food and Drug Administration (FDA), becoming the first and only prescription strength ... Read More

Lupin bags tentative approval for Ocaliva Tablets generic in US

Pallavi Madhiraju- March 24, 2023 0

Lupin said that it has been issued tentative approval for Obeticholic Acid Tablets, 5 mg and 10 mg from the US Food and Drug Administration ... Read More

Lupin partner Caplin Steriles gets FDA nod for Zemuron Bromide generic

Pallavi Madhiraju- March 21, 2023 0

Lupin Limited said that its alliance partner Caplin Steriles has won final approval for Rocuronium Bromide Injection, 10mg/mL in 5 mL and 10 mL multi-dose ... Read More

Glenmark Pharmaceuticals set to begin clinical trial of GRC 54276 in US

Pallavi Madhiraju- March 17, 2023 0

Glenmark Pharmaceuticals, through its subsidiary Glenmark Specialty, is set to begin a first-in-human, phase 1/2 clinical study of GRC 54276 in the US for the ... Read More